The material at the heart of the study is a thermosensitive hydrogel loaded with two types of functional nanomaterials: flower-shaped nanoparticles of molybdenum disulfide (MoS2) and zinc oxide (ZnO) nanoparticles, all embedded within a matrix formed from tannic acid and glycerol monostearate derivatives. The researchers designated this composite MoS2–ZnO@TM/TA. Each component plays a distinct role. The MoS2 nanoflowers are potent photothermal agents: when illuminated with near-infrared (NIR) light, they absorb the radiation and convert it into localized heat with high efficiency. ZnO nanoparticles contribute intrinsic antibacterial activity, partly through the release of zinc ions, which disrupt bacterial membranes and metabolism, and partly through their capacity to modulate reactive oxygen species. Tannic acid, a plant-derived polyphenol, acts as a natural crosslinker and antioxidant, while the lipid-derived monoglyceride component confers the temperature-sensitive gelation behavior that makes the material injectable.

The physical characterization of the hydrogel reveals a suite of properties that are unusually well matched to the demands of wound treatment. At room temperature in phosphate-buffered saline, the material swells to 93 percent of its capacity, allowing it to absorb wound exudate without dissolving. More striking is its shear-thinning rheology: when the shear rate applied to the material increases from 0.1 to 100 per second, its viscosity plummets from 1423 millipascal-seconds down to just 26. In practical terms, this means the hydrogel is thick and stable when sitting still, but flows readily when pushed through a syringe needle. Once deposited into the irregular geometry of a wound bed, it resettles into a soft, conformal gel that maintains intimate contact with the tissue. This injectability is a significant advantage over preformed dressings, which often fail to fill deep or unevenly shaped lesions.

The hydrogel’s responsiveness does not stop at shear. The material also exhibits temperature- and pH-sensitive behavior, which is critical because diabetic wounds present an abnormal microenvironment: they tend to be warmer than healthy skin, more acidic due to accumulated lactic acid and bacterial metabolism, and enriched in degradative enzymes. By tuning the gel matrix so that its structure and release profiles respond to these cues, the researchers built a degree of “intelligence” into the dressing. The hydrogel remains stable under normal conditions but becomes more active precisely where the pathological conditions of a chronic wound exist, delivering its therapeutic payloads where they are needed most and limiting off-target effects on healthy surrounding skin.

The photothermal performance of the composite is central to its antibacterial power. Under near-infrared light at an irradiance of 0.8 watts per square centimeter, the hydrogel raises the local temperature to 53 degrees Celsius within just eight minutes. This level of heating is lethal to bacteria but, when carefully controlled, tolerable for surrounding tissue over short exposures—a therapeutic window that photothermal therapy strategies have exploited in recent years. The heat disrupts bacterial membranes, denatures essential proteins, and, crucially, attacks the extracellular polymeric substance matrix that glues biofilms together. Biofilms are notoriously resistant to conventional antibiotics, with embedded cells often tolerating drug concentrations hundreds to thousands of times higher than their free-swimming counterparts. Physical heat penetrates this protective matrix in a way that molecules often cannot.

The antimicrobial results reported in the study are dramatic. The photothermal hydrogel achieved a 98 percent kill rate against both multidrug-resistant Escherichia coli and multidrug-resistant Staphylococcus aureus, two of the most clinically worrisome wound pathogens. Against established biofilms, the material cleared more than 80 percent of the biomass. These figures matter because multidrug-resistant infections are rising globally, and the World Health Organization has identified antimicrobial resistance as one of the top threats to public health. A dressing that does not rely on antibiotics at all, but instead on physical and nanoscale mechanisms that bacteria have difficulty resisting, offers a valuable alternative in the arms race against resistant organisms.

Mechanistically, the system operates through what the authors describe as a synergistic triad of “photothermal sterilization, inflammatory repair, and microenvironment regulation.” The MoS2 nanoflowers generate the heat that kills bacteria and breaks up biofilms. The ZnO component provides ongoing ion-based antimicrobial pressure between light treatments and contributes zinc ions that support tissue repair processes. The tannic acid within the network scavenges excess reactive oxygen species, which are known to accumulate in chronic wounds and perpetuate tissue damage, while also modulating the inflammatory response that otherwise stalls healing in the chronic phase. Together, these actions shift the wound from a destructive, bacteria-dominated state toward one permissive for cell migration, angiogenesis, and new tissue formation.

The in vivo evidence comes from experiments in diabetic mouse models, which are the standard preclinical platform for wound-healing studies. The results were striking. By day 9 after hydrogel treatment, new skin tissue had already emerged over the treated wounds—a stage at which untreated lesions typically remain open and inflamed. By day 21, the wounds treated with the hydrogel showed a healing rate approximately 50 percent higher than that of the blank control group. Histological assessments accompanying the study indicated improved re-epithelialization and tissue organization in the treated animals. The researchers also reported that the material is biocompatible, an essential prerequisite for any clinical translation, with no significant toxicity observed toward host cells in the tested conditions.

The broader significance of this work lies in how it reframes the problem of diabetic wound care. Traditional dressings are largely passive: they keep the wound moist and provide a physical barrier, but they do little to actively reshape the hostile biology of a chronic lesion. Antibiotic-laden dressings face the twin problems of resistance and off-target disruption of beneficial microbes. The MoS2–ZnO@TM/TA hydrogel represents a third path—an active, multifunctional platform that senses and responds to the wound environment, physically destroys biofilms with light-triggered heat, and simultaneously calms the inflammatory storm that keeps diabetic wounds frozen in a non-healing state. The ability to inject the material also opens the door to minimally invasive application, potentially allowing clinicians to treat deep or tunneling wounds that conventional dressings cannot reach.

Challenges remain before such a system could reach patients. The study relies on near-infrared light delivered from an external source, which raises questions about penetration depth in thick or deeply located tissues, and the long-term fate of the inorganic nanoparticles within the body will require careful toxicological scrutiny. Scaling up the synthesis of well-characterized MoS2 nanoflowers and ensuring batch-to-batch consistency are further hurdles. Nevertheless, the convergence of injectability, on-demand photothermal activation, antibiotic-free bacterial killing, and microenvironment-responsive behavior in a single material marks a substantial advance. For the millions of people worldwide at risk of diabetic foot ulcers—lesions that too often end in amputation—this multifunctional hydrogel offers a glimpse of a future in which wound dressings do far more than cover an injury: they actively fight it.

The work, led by Qin Lu and corresponding author Hui He at Guangxi University’s Guangxi Key Laboratory of Clean Pulp & Papermaking and Pollution Control, tackles a challenge that has long frustrated the field of advanced wound management. Infected scald wounds are notoriously difficult to treat because they present clinicians with two coupled problems: an unpredictable microbial burden that can flare without warning, and a moist, acidic microenvironment that conventional dressings neither monitor nor exploit. The new dressing merges sensing and therapy into a single flexible platform, built from three functionally distinct “hives” arranged in a honeycomb-topological pattern.

The first of these functional modules is what the researchers call the “beeway,” a monitoring channel inlaid with atomically precise gold nanoclusters. Gold nanoclusters — aggregates consisting of only tens to hundreds of gold atoms, small enough that their electronic properties become dominated by quantum effects — are prized in biosensing for their strong fluorescence and chemical specificity. The team used two elegant physical mechanisms to embed them: the nanoconfinement effect, in which the restricted geometry of nanoscale pores forces molecules into precise arrangements, and molecular stacking, in which the ordered layering of molecules produces enhanced optical behavior. Confined within the beeway’s structure, the gold nanoclusters act as a fluorescence-based reporter system. When reactive oxygen species associated with bacterial infection accumulate in the wound bed, the fluorescence signal changes in a quantifiable way. In practical terms, this means the dressing itself becomes a diagnostic instrument: the intensity of the light it emits correlates with the severity of infection, allowing caregivers to track microbial load without repeatedly disturbing or removing the bandage.

The second module addresses fluid management through what the team describes as Janus hives — structures named for the two-faced Roman god because they possess asymmetric wettability, meaning one face attracts water while the other repels it. This asymmetry produces unidirectional liquid transport: wound exudate, blood, and other biological fluids are drawn away from the wound surface and through the dressing in a single direction, but cannot flow backward. The importance of this design principle in wound care is difficult to overstate. Excess exudate pools around infected wounds, macerating surrounding skin and providing a nutrient-rich breeding ground for bacteria. Dressings that simply absorb fluid eventually saturate; dressings that allow backflow can recontaminate the wound. By engineering one-directional clearance into the honeycomb’s hexagonal cells, the researchers created a self-draining architecture that also serves a second purpose — the directional flow facilitates the delivery of therapeutic molecules from the dressing’s reservoirs into the wound itself.

The third module is where the therapy happens. The therapeutic hives consist of an entangled network of photothermal and photosensitive cellulose nanofibers — ultrathin fibers derived from cellulose, one of the most abundant biopolymers on Earth. Within this nanofiber network, the researchers confined intelligent photosensitive molecules using the same nanoconfinement strategy that underpins the sensing module. Under illumination with an 808-nanometer near-infrared laser, the photothermal components convert light energy into localized heat, a well-established antibacterial mechanism that damages bacterial membranes and proteins. At the same time, the photosensitive components generate singlet oxygen, denoted ¹O₂, a highly reactive molecular species that chemically oxidizes and destroys bacterial cells. This dual photothermal-photodynamic attack, triggered only by external light, offers a controllable alternative to systemic antibiotics — an increasingly urgent consideration as antibiotic resistance spreads worldwide.

What elevates the design from a static antimicrobial patch to an intelligent therapeutic system is its responsiveness to the wound’s own microenvironment. Infected wounds tend to be acidic, and the therapeutic hives exploit this. The acidic microenvironment stimulates the release of the confined photosensitive molecules from the nanofiber network into the deeper tissues of the wound. Once released, these molecules can be re-activated by a 660-nanometer laser to produce additional singlet oxygen, effectively eradicating bacteria continuously across successive treatment cycles. The mechanism is a form of chemical feedback: the very acidity produced by infection and inflammation triggers a stronger therapeutic response precisely where it is needed most. Bacterial persistence deep within wound tissue — a major cause of treatment failure and chronic wound formation — is thus targeted by molecules that migrate under acidic stimulation rather than remaining locked at the surface.

The honeycomb topology itself is more than aesthetic inspiration. Hexagonal tiling is nature’s most efficient packing geometry, combining maximal area coverage with minimal material use and exceptional mechanical resilience. In a flexible dressing, this geometry provides a continuous, interconnected network of functional compartments, each performing its role — sensing, drainage, or therapy — while the overall structure remains soft, conformable, and breathable. That flexibility matters clinically: rigid or stiff smart dressings have struggled to transition from the laboratory to real wounds, which bend, stretch, and flex with the body. By constructing the honeycomb architecture from cellulose nanofibers, the Guangxi team anchored their platform in a material class that is inherently flexible, biocompatible, and sustainable.

In experiments on complex infected scald wounds, the integrated system achieved what the authors describe as intelligent monitoring and therapy working in concert — the fluorescent beeway quantifying infection severity, the Janus hives maintaining a clean wound surface, and the therapeutic hives eradicating bacteria under light activation while releasing deep-penetrating photosensitizers in response to acidity. Crucially, the researchers report that the dressing achieved scarless healing, an outcome that carries enormous significance for burn patients, for whom scarring can mean lifelong mobility impairment and disfigurement. Scar formation results from disordered collagen deposition during healing; steering wounds toward regenerative repair without fibrotic scarring remains one of the central aspirations of regenerative medicine, and few antimicrobial platforms have claimed that capability.

The broader significance of the work lies in its demonstration of a general design principle. The authors frame their study as providing “a path for the coupling of intelligent molecules and nanoclusters in nanoconfined dressing spaces” — a recipe, in other words, that others in the field could adapt. The nanoconfinement effect and molecular stacking, the two physical mechanisms that organize the gold nanoclusters and photosensitive molecules within the dressing’s nanoscale architecture, are not limited to wound care. They represent a strategy for placing functional molecules exactly where their properties — fluorescence, reactivity, stimulus-responsiveness — can be harnessed in a controlled, addressable way. That could extend to smart bandages for diabetic ulcers, implantable infection sensors, or light-triggered drug delivery platforms.

The timing is notable. With antimicrobial resistance contributing to hundreds of thousands of deaths annually and chronic, infected wounds consuming a growing share of healthcare resources, the demand for materials that can diagnose and treat at the point of care has never been higher. A dressing that reports its own assessment of infection severity and then mounts a light-triggered, microenvironment-responsive antibacterial campaign — without antibiotics — suggests a future in which the humble bandage becomes one of the most sophisticated medical devices a patient encounters. The research, which received support from the National Natural Science Foundation of China and the Guangxi Natural Science Foundation, among other funders, has been published as a citable open-access article, with the authors declaring no competing interests.

As the field of intelligent wound dressings accelerates, the honeycomb-topological platform stands out for its integration: one flexible material, three coordinated functions, and a feedback loop that lets the wound itself direct the therapy. Whether such systems can be manufactured at scale and validated across the full diversity of clinical wounds will determine their trajectory, but as a proof of principle, the Guangxi team’s work offers a compelling glimpse of wound care’s next generation.

Gelatin is a particularly attractive foundation for this type of biomaterial because it is derived from collagen, the major structural protein in skin and connective tissue. When processed into a wound dressing, gelatin can form a moist, flexible matrix that conforms to irregular tissue surfaces. Moisture retention is important because excessive drying can damage newly formed cells, while a controlled moist environment can support cell migration and tissue repair. Gelatin is also biodegradable, meaning that the body can gradually break it down after the wound has begun to heal. However, gelatin alone does not necessarily provide sufficient mechanical strength, antibacterial protection or rapid bleeding control. The new formulation therefore uses gelatin as a biological framework and adds nanoscale calcium carbonate, gentamicin and curcumin to give the dressing a broader therapeutic profile.

Calcium carbonate nanoparticles are central to the material’s proposed hemostatic action. Calcium ions are essential participants in the coagulation cascade, the chain of biochemical reactions that converts liquid blood into a protective clot. When a wound occurs, platelets adhere to the damaged surface and become activated, while a series of clotting factors ultimately helps generate fibrin, a protein that forms a mesh over the injury. A dressing containing calcium carbonate may provide a local source of calcium as the mineral interacts with the wound environment. The particles can also increase the surface area available for blood components to interact with the dressing, potentially helping blood concentrate and clot at the site of injury. These effects are especially relevant for dressings designed for trauma, surgery or wounds where rapid control of bleeding is critical.

The nanoscale form of calcium carbonate may also influence how the dressing behaves after it is applied. Nanoparticles have a high surface-area-to-volume ratio, allowing them to interact efficiently with surrounding fluids and with the gelatin network. Their distribution throughout the polymer matrix may affect the dressing’s porosity, swelling and degradation. Those characteristics determine how quickly wound fluid enters the material and how readily active compounds move out of it. A carefully engineered porous structure can absorb excess exudate while maintaining contact with the wound. At the same time, gradual disintegration of the gelatin and mineral components could help create a localized release system, keeping therapeutic agents near the injury rather than allowing them to disperse immediately across the body.

Gentamicin provides the formulation’s conventional antibacterial component. This aminoglycoside antibiotic acts primarily by entering susceptible bacterial cells and binding to bacterial ribosomes, the molecular machines responsible for producing proteins. By disrupting protein synthesis, gentamicin can cause the formation of faulty proteins and ultimately damage the bacterial cell. Delivering the antibiotic from a wound dressing may offer a way to establish high concentrations at the contaminated surface while limiting the need for repeated systemic administration. Local delivery is not automatically risk-free, and antibiotic exposure must be controlled to avoid toxicity and unnecessary selection for resistant organisms. Nevertheless, embedding gentamicin in a biomaterial can provide a sustained and localized antibacterial strategy, particularly during the vulnerable period immediately after injury.

Curcumin adds a second, chemically distinct dimension to the dressing. Best known as a major bioactive compound in turmeric, curcumin has been investigated for antioxidant, anti-inflammatory and antimicrobial properties. In wounds, excessive or prolonged inflammation can damage surrounding tissue and delay the transition from inflammation to repair. Curcumin may help moderate some of the molecular pathways associated with inflammatory signaling and oxidative stress, although its practical medical use has often been limited by poor water solubility, rapid degradation and weak absorption. Incorporating it into calcium carbonate nanoparticles and a gelatin matrix could improve its dispersion and keep it in contact with the wound for longer. The combined presence of curcumin and gentamicin is intended to address different aspects of the wound environment rather than relying on an antibiotic alone.

The formulation’s antibacterial concept is particularly important because open wounds can become colonized by organisms from the skin, environment or medical setting. Bacterial growth consumes nutrients, produces damaging enzymes and toxins, and can maintain inflammation that prevents new tissue from forming. Some bacteria also organize themselves into biofilms, dense communities surrounded by a protective matrix that makes them harder to eliminate. A dressing that physically covers the wound while releasing antibacterial agents could create several barriers at once. Gentamicin targets susceptible bacteria directly, while curcumin may contribute additional antimicrobial and anti-inflammatory activity. The calcium carbonate and gelatin matrix can act as the delivery vehicle, controlling how the compounds are presented to the tissue. The effectiveness of this strategy depends on release rate, bacterial susceptibility and the ability of the dressing to maintain adequate contact with the wound.

Biocompatibility is a decisive requirement for any material intended to remain against injured tissue. A dressing may be antibacterial and hemostatic yet still fail if it causes significant irritation, damages healthy cells or provokes an unwanted immune response. Gelatin is generally considered biologically compatible, but its source, processing method and degree of purification can influence performance. Likewise, nanoparticle size, concentration and surface characteristics can affect how cells respond to calcium carbonate. The research therefore places emphasis on a formulation that can perform several tasks without becoming harmful to the surrounding tissue. In practical terms, an ideal dressing would adhere gently, absorb wound fluid, stop bleeding, limit microbial growth, release its active ingredients in a controlled manner and eventually degrade or be removed without disrupting newly formed tissue.

The study represents a broader movement in biomedical engineering toward multifunctional wound-care materials rather than single-purpose coverings. Conventional gauze can absorb blood but does not necessarily provide sustained antibacterial treatment or actively support healing. Advanced dressings may incorporate polymers, nanoparticles, antibiotics, plant-derived compounds and biological signals into one engineered system. The gelatin-based calcium carbonate platform described in Scientific Reports follows that trend by combining hemostasis, antimicrobial delivery and biocompatibility in a single dressing architecture. Its eventual clinical value will depend on evidence beyond material fabrication, including detailed release studies, cytocompatibility testing, antibacterial performance against clinically relevant strains, animal wound models and carefully designed human trials. Questions about long-term storage, manufacturing consistency, antibiotic resistance and performance in complex wounds will also need to be addressed. Even so, the concept highlights how nanoscale engineering can turn a simple wound covering into an active therapeutic interface between medicine and damaged tissue.

Subject of Research: A biocompatible gelatin-based wound dressing containing calcium carbonate nanoparticles loaded with gentamicin and curcumin, designed for hemostatic and antibacterial wound care.

Article Title: A biocompatible hemostatic and antibacterial gelatin-based wound dressing containing calcium carbonate nanoparticles loaded with gentamicin and curcumin.

Article References: Maleki Dizaj, S., Sharifi, S., Memar, M.Y. et al. “A biocompatible hemostatic and antibacterial gelatin-based wound dressing containing calcium carbonate nanoparticles loaded with gentamicin and curcumin.” Scientific Reports (2026). https://doi.org/10.1038/s41598-026-65723-x

Image Credits: AI Generated

DOI: 10.1038/s41598-026-65723-x

Keywords: gelatin wound dressing, calcium carbonate nanoparticles, gentamicin, curcumin, hemostasis, antibacterial biomaterials, wound healing, nanomedicine, biocompatibility

The newly engineered P-EPL/CCT hydrogel exhibits a striking balance of mechanical robustness and elasticity, boasting a maximum stress tolerance of 2.15 MPa and an exceptional elongation capability up to 605%. This amalgamation of strength and flexibility makes the hydrogel highly adaptable for dynamic environments on human skin, where mechanical demands continuously vary. These mechanical properties are paramount for wearable biomedical devices, ensuring durability during regular motion without compromising function or comfort.

One of the most compelling attributes of this organohydrogel is its remarkable antifreeze resistance, maintaining functional integrity down to an unprecedented −39.5 °C. This antifreeze capability enhances the hydrogel’s applicability in diverse climatic conditions and during long-term storage, addressing a critical challenge in hydrogel-based wearable sensors and therapeutic materials. By preventing ice crystallization within the matrix, the hydrogel preserves its mechanical and conductive properties, which are essential for consistent sensor performance.

Antimicrobial efficacy is a cornerstone of this hydrogel’s design, featuring bacterial inhibition rates exceeding 96.5%. Infused with lysozyme and tannic acid, known for their potent antimicrobial activities, the hydrogel acts as an active barrier against infection—a vital function for wound dressings treating burn injuries where bacterial colonization poses substantial risks. This built-in antimicrobial characteristic not only protects the wound but also reduces the reliance on external antibiotics, potentially mitigating resistance issues.

The hydrogel’s biocompatibility was rigorously evaluated to ensure safety for direct skin contact and cellular interaction. Cytocompatibility tests confirmed that the material supports cell viability, an essential prerequisite for biomedical implants and wound dressings aimed at facilitating natural tissue regeneration. This property highlights the hydrogel’s suitability for prolonged application on delicate and injured skin, ensuring it fosters rather than impedes the healing process.

Functionality extends beyond therapeutic applications, as the hydrogel has been engineered to serve as a high-sensitivity strain sensor. With a gauge factor (GF) of 1.14 at 100% strain, it demonstrates a superior ability to detect and quantify mechanical deformation. This sensitivity is crucial for accurately monitoring human movement signals in real-time, which can provide invaluable data for clinical assessments during rehabilitation and recovery from joint or musculoskeletal injuries.

In addition to sensitivity, the hydrogel exhibits rapid response times, a characteristic that significantly enhances its performance as a wearable sensor. This responsiveness enables instantaneous feedback on strain or pressure changes, an attribute that is critical for dynamic monitoring of physiological signals in ambulatory patients or athletes. The integration of electrical conductivity within the organohydrogel facilitates direct transduction of mechanical stimuli into readable electronic signals.

The wound healing capabilities of the hydrogel transcend simple coverage and protection. The device actively accelerates skin repair by promoting angiogenesis—the formation of new blood vessels—thereby improving vascular supply to the affected area. Additionally, the hydrogel reduces scar formation, potentially through the controlled release of bioactive agents and its conducive microenvironment, which supports organized tissue regeneration rather than fibrotic scarring.

The developers have harnessed the hydrogel’s electronic properties to establish a smart wound monitoring system. By coupling the flexible strain sensor with machine learning algorithms, they have demonstrated an intelligent platform capable of analyzing electrical signal patterns to assess wound status and progression objectively. This innovation signifies a leap toward personalized and precise wound management, offering real-time diagnostics that empower clinicians to optimize treatment plans dynamically.

The hydrogel’s utility extends to monitoring finger joint injuries, where nuanced movements demand flexible yet accurate sensors. Its high elasticity and mechanical strength provide the necessary durability and conformability, capturing subtle joint dynamics without restricting mobility. This function is particularly beneficial in rehabilitation settings, where continuous movement tracking can accelerate recovery and guide therapeutic interventions.

This multifunctional organohydrogel stands as a testament to the power of interdisciplinary collaboration, combining expertise in polymer chemistry, materials engineering, and biomedical sciences. The research team, led by Chuang Du of the Changchun Institute of Applied Chemistry, Weiwei Liu from the Stomatological Hospital of Jilin University, and Lei Wang at the Key Laboratory of Molecular Enzymology and Engineering, epitomizes the global effort to translate advanced materials into clinical breakthroughs.

The development of the P-EPL/CCT hydrogel not only addresses immediate clinical needs following fireworks-related burns but also paves the way for the next generation of wearable biomedical devices. By fusing mechanical resilience, biocompatibility, antimicrobial protection, and intelligent sensing, this innovation heralds new horizons in personalized healthcare, especially in emergency response and chronic wound management. Its versatility and multifunctionality make it a promising candidate for widespread adoption in diverse medical applications.

Looking ahead, further clinical trials and large-scale production studies will be instrumental in bringing this technology from the laboratory to bedside. Optimization for mass manufacturing, long-term biostability assessments, and integration with other digital health systems will enhance its transformative potential. As researchers continue to refine these materials, multifunctional hydrogels such as the P-EPL/CCT system will undoubtedly redefine standards in wound care and wearable sensing technology.

In sum, this study highlights a significant stride toward multifunctional biomaterials that fuse therapeutic effectiveness with advanced monitoring capabilities. The P-EPL/CCT conductive hydrogel sensor epitomizes innovation at the nexus of chemistry, materials science, and clinical medicine, offering a multipronged solution for managing burns, improving healing outcomes, and enhancing rehabilitation through intelligent sensing technology.

Subject of Research: Multifunctional conductive hydrogel sensors for emergency burn treatment and wound healing monitoring

Article Title: Development of a multifunctional conductive organohydrogel with mechanical robustness, antifreeze resistance, antimicrobial property, and intelligent sensing for wound healing and human motion monitoring

News Publication Date: Information not provided

Web References: Information not provided

References: Information not provided

Image Credits: Content/Public from Polymer Science & Technology publication

Keywords: Conductive hydrogel, wound healing, burn treatment, multifunctional sensor, antifreeze properties, antimicrobial hydrogel, biocompatible materials, strain sensor, flexible electronics, angiogenesis, machine learning, intelligent wound monitoring